NTRK2 and myeloid sarcoma: Consistent with our findings, BDNF and its receptor truncated trkB tyrosine kinase receptor were detected in lesions of MS patients (Stadelmann et al., 2002) as well as EAE (Stadelmann et al., 2002; De Santi et al., 2009; Colombo et al., 2012).